​

Day One Biopharmaceuticals (DAWN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Day One Biopharmaceuticals Revenue Highlights

0

Latest Revenue (Q)

$20.07M

Day One Biopharmaceuticals Revenue by Period

Day One Biopharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Day One Biopharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Day One Biopharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$20.07M145.00%
2024-06-30$8.19M100.00%
2024-03-31--100.00%
2023-12-31$560.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Day One Biopharmaceuticals generated $20.07M in revenue during Q3 2024, up 145.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Day One Biopharmaceuticals Revenue Breakdown

Day One Biopharmaceuticals Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24
License$73.69M-
Product$20.07M$8.19M

Day One Biopharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: License (78.59%), and Product (21.41%).

Day One Biopharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
XFORX4 Pharmaceuticals-$560.00K
PDSBPDS Bio--
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
ELDNEledon Pharmaceuticals--

DAWN Revenue FAQ

What is Day One Biopharmaceuticals’s yearly revenue?

Day One Biopharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. DAWN's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Day One Biopharmaceuticals’s quarterly revenue?

Day One Biopharmaceuticals's quarterly revenue for Q3 2024 was $20.07M, a 145.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $8.19M, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). DAWN's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Day One Biopharmaceuticals’s revenue growth rate?

Day One Biopharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.